In stroke therapy, EVs loaded with nerve growth factor (NGF) (e.g., RVG-EV) notably enhance NGF expression in the infarcted region, reduce inflammation, and promote cell survival (Yang et al., 2020). This evidence concerns the gene NGF and Stroke.